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Disorders of sex development (DSD) may be the most devastating condition after perinatal mortality, to face by any parent of a newborn, not only with the uncertainty 
involved in determining the sex of the child, but also with the 
social stigma attached to it [1-3]. DSD or the transgender as it is 
called now may be identified in later childhood or after marriage 
or even after evaluating for infertility in a couple. Although legally 
the term transgender is going to be in records, their psychosocial 
and sexual problems cannot be solved with our existing social 
conditions. No single protocol is available for treatment and in 
the most cases even workup may not be fully completed. When 
the gender of an intersex child was wrongly assigned at birth, 
subsequent gender re-assignment creates some of the most 
emotional and contentious ethical dilemmas encountered in 
any area of medical practice. Due to the social stigma attached 
to the condition, many won’t turn up for follow-up. We cannot 
construct male genitalia. Hence, to avoid a change in sex later, 
it is necessary to predict the pubertal change, sexual outcome, 
gender identity and gender role in any case of DSD so that they 
can be reared in the most suitable sex for them.
There are no solid long-term outcome studies on patients 
managed with intersex disorders in current literature. In this context, 
we tried to find out the gender outcome of children with DSD in our 
hospital, for emphasizing the social emergency of the situation.
MATERIALS AND METHODS
The research protocol of the study was submitted to the Research 
and Human Ethical Committee of the institution. The study was 
started after getting the clearance from both the committees. 
Children from birth up to 12 years of age, who fulfilled the 
criteria for DSD according to the standard literature [4,5] and 
who came to our pediatric outpatient (OP) clinic, pediatric wards 
and endocrinology clinic during 1-year period (1st January 2010 
to 31st December 2010) were enrolled. All the cases of DSD in 
the endocrinology OP registry over 10-year period (1st January 
2000-31st December 2009) were called for both by letter and 
telephone. All consecutive cases who responded to the call were 
enrolled in the study after getting an informed consent. Hence, 
28 old cases were analyzed and evaluated. 10 fresh cases were 
recruited over the study period. Thus, a total of 38 patients were 
enrolled in the study.
A pro forma was prepared with personal data including age 
at first presentation, current age, assigned gender at birth, sex 
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of rearing, gender identity, consanguinity, antenatal history and 
drugs, family history, initial presenting complaints, general 
examination, hyperpigmentation, state of hydration, auxology, 
blood pressure, description of genitalia at presentation (from 
old records also), initial investigations - laboratory/karyotyping/
imaging/laparoscopy/biopsy), initial diagnosis and treatment 
received (medical/surgical), current appearance of external 
genitalia (Prader staging), reinvestigations done if any, revised 
diagnosis if any, treatment planned, follow-up pattern (regular/
irregular) and reason for irregular follow-up.
The genital ambiguity inclusive of the symmetry of the 
labioscrotal folds, labial fusion, phallic length, morphology of 
the phallus, number of urogenital openings, palpable gonads, 
and the site of gonad, position of urethral opening, chordee and 
anogenital ratio were recorded to describe the stage of virilization. 
A newborn was considered to have DSD when the baby satisfied 
the criteria as shown in Table 1 [4,5].
Laboratory investigations included serum electrolytes, 
random blood sugar, renal function and electrolytes, hormonal 
studies like basal concentration of 17-hydroxyprogesterone 
(17-OHP), testosterone, dihydrotestosterone (DHT), 
dehydroepiandrosterone, follicle stimulating hormone, and 
luteinising hormone according to the clinical diagnosis. 
In doubtful cases, adrenocorticotropic hormone (ACTH) 
stimulation test was done with an intravenous bolus of 0.125 mg 
of ACTH to observe the rise in 17-OHP (one of our cases 
needed it). However, 11 deoxycortisol or deoxycorticosterone 
was not available in our settings to type the congenital 
adrenal hyperplasia (CAH). In some cases, human chorionic 
gonadotropin (hCG) stimulation test was done after 3 months 
by giving 1000 units hCG IM on alternate days for 3 doses to 
study the levels of testosterone and DHT.
Pelvic and abdominal ultrasonography helped to detect the 
presence of gonads and mullerian structures. Other investigations 
included genitogram, laparoscopy, and gonadal biopsy. For older 
cases, the previous investigations were analyzed, re-examination 
was done and needed investigations were conducted to arrive 
at a definitive diagnosis. Polymerase chain reaction for SRY or 
mutation analysis for enzyme defects was not available in our 
settings. Karyotyping was done for all patients on peripheral 
blood lymphocytes. From the clinical examination and the 
investigations, we arrived at the etiological diagnosis of DSD 
following the standard protocols [6].
RESULTS
In the study group, the age at diagnosis ranged from birth till 
12 years. 50% (n=19) of the cases were identified in the newborn 
period itself. An additional 10.5% (n=4) cases were identified 
before 1 year; hence, a total of 60.5% cases were diagnosed in 
infancy. 21.05% (n=8) and 18.42% (n=7) of cases were identified 
between 1 and 5 years and after 5 years of age, respectively. The 
cases presented after 5 years included 3 cases of simple virilizing 
type of CAH and 2 cases of complete androgen insensitivity 
syndrome (CAIS) and 2 cases of partial androgen insensitivity 
syndrome (PAIS). According to the clinical, laboratory and 
imaging studies, the 38 cases were classified as per the latest 
recommendations as shown in Table 2 [6]. The majority of the 
cases were CAH followed by CAIS.
At birth, 22 (57.89%) children were assigned as females, 
8 (21.05%) were assigned as male and 8 (21.05%) cases were not 
assigned any sex. Presently, 28 (73.7%) cases are being reared 
Table 1: Clinical definitions and criteria [4,5]
DSD: Atypical development of genital, gonadal and phenotypic sex 
with respect to chromosomal sex
Ambiguous genitalia: When there is difficulty in assigning sex to 
an individual from the appearance of external genitalia or when 
phenotypic sex is neither completely male nor female
DSD in the newborn period: (1) A phallus and bilaterally 
non palpable testis, (2) unilateral cryptorchidism and 
hypospadias, (3) penoscrotal or perineoscrotal hypospadias with or 
without microphallus even if the testis are descended, (4) discordance 
of external genitalia compared with prenatal karyotype, (5) apparently 
female appearance with enlarged clitoris or inguinal hernia, (6) overt 
genital ambiguity such as cloacal extrophy, (7) asymmetry of 
labioscrotal folds with or without cryptorchidism
Prader staging: Complete female (Type 5), partial female (Type 4), 
ambiguous (Type 3), predominantly male with micropenis (Type 2), 
and completely male phenotype without apparent 
undervirilization (Type 1)
Gender role: It is a set of societal norms dictating what types of 
behaviours are generally considered acceptable, appropriate, or 
desirable for a person based on their actual or perceived sex
Gender identity: Personal conception of oneself as male or female (or 
both or neither)
DSD: Disorders of sex development
Table 2: Etiological classification [6]
Type Frequency (n=38)
46, XX DSD 17 (44.7)
CAH-salt losing 8 (21.1)
CAH-simple virilizing 8 (21.1)
Genital malformation 1 (2.6)
46, XY DSD 17 (44.7)
CAIS 6 (15.79)
PAIS 3 (7.9)
5 alfa reductase deficiency 3 (7.9)
Pure gonadal dysgenesis 1 (2.6)
PMDS 1 (2.6)
Incomplete work up 3 (7.9)
Sex chromosome DSD 2 (5.26)
47 XXY 1 (2.63)
49XXXXY (50)/48XXXY (30)/46XY (20) 1 (2.63)
Ovotesticular DSD 2 (5.26)
46, XY 1 (2.63)
46XX/46XY 1 (2.63)
46 XX testicular DSD 0 (0)
CAH: Congenital adrenal hyperplasia, CAIS: Complete androgen insensitivity 
syndrome, PAIS: Partial androgen insensitivity syndrome, PMDS: Persistent 
mullerian duct syndrome, DSD: Disorders of sex development, CAH: Congenital 
adrenal hyperplasia
Rahul and Saraswathyamma “Gender outcome” in children with sex development disorders
Vol 4 | Issue 2 | Apr - Jun 2017 Indian J Child Health 116
as females and only 10 cases (26.3%) as males. Among those 
who were assigned as females, 100% continued to be so. Among 
those who were assigned as males, 25% (n=2) changed to female 
sex. Among those who were not assigned any sex at birth, 50% 
became phenotypic male and 50% became phenotypic female. 
Hence, there was a significant proportion of change in sex after 
initial assignment. Table 3 shows the trend of change in sex.
Assigned sex at birth and sex of rearing according to the 
various etiological diagnoses and according to the chromosomal 
sex are given in Tables 4 and 5, respectively.
DISCUSSION
For a proper gender identity and a gender role in the community, it 
is better to have no change in sex after 2 years because in humans, 
environment also is a powerful mediator of gender identity and 
behavior [6-8]. In our study, the cases presented after 5 years 
of age included androgen insensitivity syndromes (Fig. 1) and 
simple virilizing type of CAH. The later ones were XX only, and 
they can be continued as females if proper treatment is planned. 
However, the former ones created the worst mental stress, initially 
for the parents and later to the kids as well, as they knew that they 
are genetically males.
Change of gender from that at birth is an important matter for 
discussion. Although all who were assigned female sex at birth 
continued to be so, many cases of CAH who were detected earlier 
and with no regular follow-up, came with abnormal looking 
genitals (Fig. 2). Many of them have partial male gender identity 
as well. Among those who were assigned male sex, two cases 
of CAH changed to female later. Among those who were not 
assigned any sex at birth, 50% each became males and females 
(Tables 3 and 4). Hence, in doubtful cases, do not label these 
children any sex till the evaluation is completed.
Knowing the etiology can predict the gender outcome. Among 
46, XX CAH, at birth 81.25% of babies was assigned female sex, 
12.5% were assigned male sex and 6.25% were undetermined. 
However, all are now being reared as females. In a study by 
Al-Mulhaim et al., all the newborns with 46 XX CAH were raised 
as females and those with delayed presentation of CAH were reared 
as male [9]. That signifies the importance of identifying XX CAH 
earlier because severe variety may get misinterpreted as males at 
birth and cannot be reared as females if they are presenting very 
late because they will be having male gender identity and gender 
role due to the androgenic influence on brain [10,11]. However, a 
correctly managed XX CAH can have a normal life with normal 
reproductive functions. Those who are being reared as males will 
be impotent, will not be having a complete male phenotype and 
finally will be identified in community as transgender. 46 XX 
with local genital malformation can also be improved by genital 
reconstruction. Hence, this study emphasizes that all XX DSDs 
should be reared as females only [12,13].
Due to the varied etiology, assigning sex to a 46 XY DSD 
needs proper thinking and evaluation. No single protocol is 
available. In our study, those XY children who were raised as 
females included CAIS, PAIS, and pure gonadal dysgenesis. In a 
study by Gollu et al., those XY raised as females included CAIS, 
PAIS and 5-α reductase deficiency [14]. All cases of CAIS were 
assigned female sex at birth and now also being reared as females. 
They have undergone vaginoplasty and testes were removed. 
Among PAIS, 66.6% were assigned female sex and 33.3% had an 
undetermined sex at birth but all are now being reared as females. 
All of them underwent genital reconstruction procedures but are 
not under correct follow-up. About 66.6% of children with 5-α 
reductase deficiency were assigned undetermined sex, and 33.3% 
were assigned male sex at birth. All are now being reared as males.
Only one case of PMDS (Fig. 3) was there who was assigned 
male sex at birth and was also raised as male. Child had bilateral 
cryptorchidism which was ignored initially and at 5½ years 
Table 3: Relationship between assigned sex at birth and sex of 
rearing
Assigned gender at 
birth
Gender of rearing (%)
Male Female
Male (n=8) 75 (n=6) 25 (n=2)
Female (n=22) 0 (n=0) 100 (n=22)
Undetermined sex (n=8) 50 (n=4) 50 (n=4)
Table 4: Assigned sex at birth and sex of rearing of various etiological types of DSD
Aetiological types of DSD Assigned sex at birth (%) Gender of rearing (%)
Female Male Undetermined Female Male
CAH (n=16) 81.25 (n=13) 12.5 (n=2) 6.25 (n=1) 100 0
CAIS (n=6) 6 (100%) 0 0 100 0
5-α reductase deficiency (n=3) 0 33.33 (n=1) 66.66 (n=2) 0 100
Sex chromosome DSD (n=2) 0 50 (n=1) 50 (n=1) 0 100
PAIS (3) 66.66 (n=2) 0 1 (100) 100 0
PGD 1 (100) 0 0 100
PMDS 0 1 (100) 0 0 100
Ovotesticular DSD 0 1 (50) 1 (50) 50 50
Workup incomplete XY 0 66.66 (n=2) 33.33 (n=1) 0 100
46, XX genital malformation 0 0 1 (100) 100 0
CAH: Congenital adrenal hyperplasia, CAIS: Complete androgen insensitivity syndrome, PAIS: Partial androgen insensitivity syndrome, PMDS: Persistent mullerian duct 
syndrome, DSD: Disorders of sex development, CAH: Congenital adrenal hyperplasia
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male. One case of XY pure gonadal dysgenesis was assigned 
female from birth. The child had ambiguity of genitals at birth 
and was not evaluated and presented with clitoromegaly and 
right inguinal swelling at the age of 3 months. Karyotype was 
46, XY and ultrasound and laparoscopy revealed rudimentary 
uterus with bilateral fallopian tubes. Testicular biopsy revealed 
bilateral hyalinized testes. Gonadectomy and feminizing 
genitoplasty were done and now the child is being reared as 
female. The cases of XY (n=3) with incomplete workup were 
raised as males.
Combining all, only 44.4% of 46, XY patients are being reared 
as males. So before assigning a sex to any XY DSD, we should 
try to reach a correct diagnosis, should know the natural course of 
the etiological type and its pubertal change. A rough guideline is 
as follows [7,12,15].
• All cases of CAIS should be reared as females as their 
external genitals are female looking and have female 
phenotype. Although they won’t be a fertile female, they can 
have a sexual life after proper vaginoplasty.
• In PAIS or gonadal dysgenesis - If phallic length is more 
than 1.9 cm and administration of testosterone enanthate/
cypionate 25 mg IM 3-4 injections at 3-4 weeks intervals 
increases penile length to 2.5 cm, rear as male. In a term 
infant, if phallic size is <1.5 cm long and 0.7 cm wide, it is 
preferred to rear as female [13].
• Those XY DSD who are being reared as females should be 
provided with prepubertal and pubertal estrogen therapy 
for a better looking female phenotype. They may need to 
be repeated genitoplasty and vaginoplasty and should be 
counseled regarding fertility issues.
• Testicular biosynthetic defects like 17 ketosteroid reductase 
deficiency and 5-α reductase deficiency, even if reared as 
females, will adopt a male gender role at puberty due to the 
coincidental increase in Testosterone and DHT to typical 
male levels at puberty and presumably due to the direct 
action of testosterone on the phallus [16-18]. Therefore, they 
should be reared as males only, and therefore, differentiating 
PAIS from 5-α reductase deficiency at the earliest is very 
important [15].
In sex chromosome DSD, we had 2 abnormal karyotypes [19]. 
47 XXY and its variant form (49 XXXXY (50)/48 XXXY (30)/46 
XY (20)). Both are being reared as males. 49 XXXXY (50)/48 
XXXY (30)/46 XY (20) is considered to be a mosaic variant of 
Klinefelter syndrome. It is very rare to find such a mosaicism. 
Mosaic forms are due to mitotic nondisjunction after fertilization 
of the zygote. These forms can arise from a 46XY zygote or a 
47 XXY zygote.
In ovotesticular DSD, 50% (n=1) each were raised as males 
and females. Ovotesticular DSD is the rarest variant making 
only up to 10% of intersex disorders. About 70% have a 46, XX 
karyotype, fewer than 10% have 46, XY and about 20% have 46, 
XX/46, XY [20]. In our study, the karyotypes were 46 XY and 
46 XX/46 XY. The 46 XY ovotesticular DSD is a rare variety, 
and our baby presented with ambiguous genitalia at birth. On 
Table 5: Chromosomal sex and sex of rearing
Chromosomal sex Sex of rearing (%)
Male Female
46 XX (n=17) 0 (n=0) 100 (n=17)
46 XY (n=18) 44.4 (n=8) 55.6 (n=10)
Abnormal karyotypes (n=3) 66.7 (n=2) 33.3 (n=1)
Figure 3: A case of persistent mullerian duct syndrome who presented 
with bilateral cryptorchidism. Ultrasound showed mullerian 
structures. Inguinal exploration showed fallopian tubes along with 
testes
Figure 2: A case of 46, XX congenital adrenal hyperplasia salt 
wasting type with ambiguous genitalia. (a) Clitoromegaly and the 
rugouslabioscrotal folds, (b) a well-developed vaginal orifice
a b
inguinal exploration revealed testes and mullerian structures 
(fallopian tubes). Same was removed and now being reared as 
Figure 1: A case of partial androgen insensitivity syndrome, 12-year-
old sibling of a case of complete androgen insensitivity syndrome, 
when brought up for inguinal swelling and clitoromegaly (a) Inguinal 
mass was proven to be testes, (b) normal breast development, (c) 
normal vaginal orifice (but was a blind ending loop) and penile like 
phallus, (d) review after clitororeduction
c
a b
d
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examination, had microphallus, the gonads were at the root of 
scrotum and biopsy revealed bilateral ovotestes. Although being 
reared as male, the genitals were still ambiguous. The second 
one was 46 XX/46 XY chimerism of which, only few cases are 
reported in the literature. 46 XX/46 XY chimer is an individual 
in whom some cells have the male chromosome complement, 
and some have female. When more than one set of cell line with 
different sets of chromosomes make up the body, it is called 
chimerism. It occurs when two non-identical zygotes combine 
at a very early stage of development to form a single fetus. It is 
different from mosaicism where the individual originates from 
a single fetus [21]. In our study, this case was a phenotypic girl 
who presented at the age of 4 years with left inguinal swelling 
and microphallus and hypospadias. Gonadal biopsy revealed 
ovotestes with fibromuscular changes on the right side and testes 
on the left side. She had undergone genital reconstruction. In 
ovotesticular DSD, if highly virilized, rear as male if there are 
good testicular function and no uterus. Otherwise remove the 
inappropriate gonad and rear as female.
So in a nutshell, all DSDs should be managed after detailed 
discussion with parents and also with children when appropriate, 
based on the karyotype, endocrine function, genital anatomy, 
expected pubertal change and fertility issues, to assign a sex for 
rearing. The family and the doctor must accept that any treatment 
strategy may fall short of a completely normal child. A proper 
collaboration between medical, surgical, radiology, laboratory, 
social and psychology wings provides the best possible outcome. 
Proper counseling of the parents during initial presentation is 
the only way to remove the misconcepts and also to empower 
them with proper knowledge so that most of them will turn up for 
regular treatment.
There were few limitations for our study. The new cases 
detected during newborn period could not be followed up beyond 
1 year and fallacies for hormonal studies can occur during earlier 
months. Furthermore, many of our children have not reached 
pubertal age group, which is a crucial time for determining gender 
outcome.
CONCLUSION
Although major proportion of DSDs was identified in newborn 
period, 18% were identified after 5 years only, and they were 
CAH and androgen insensitivity syndromes. It is difficult to 
complete the workup in many cases of DSDs in our setting. 
Change of sex from those assigned at birth and change in gender 
role and identity were more for XY DSD. Only 44.4% of them 
are being reared as males. All those who are identified as females 
at birth (both XX and XY) and all XX DSDs are being reared as 
females only.
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